3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Rituximab
28
Lenalidomide
23
Cyclophosphamide
21
Prednisone
15
Vincristine
13
obinutuzumab
12
Doxorubicin
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
9
Bendamustine Hydrochloride
9
ibrutinib
7
Biopsy
7
pembrolizumab
6
fludarabine
6
fludarabine phosphate
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
zanubrutinib
4
venetoclax
4
tazemetostat
4
Whole-Body Irradiation
4
R-CHOP protocol
4
Etoposide
4
CT-P10
4
Prednisolone
3
Mycophenolic Acid
3
Cyclosporine
3
tisagenlecleucel
2
polatuzumab vedotin
2
orelabrutinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
EPOCH protocol
×
90 days
×
Clear all
No trials found.